20 years of experience
Video profile
Accepting new patients
Crescent Park
21st Century Oncology
601 Redstone Ave W
Crestview, FL 32536
Locations and availability (5)

Education ?

Medical School Score Rankings
University of Miami (1990)
Internal Medicine
  • Currently 3 of 4 apples
Top 50%

Awards & Distinctions ?

Florida State University School Of Medicine
American Society of Clinical Oncology
American Board of Radiology
American Society for Therapeutic Radiology and Oncology

Affiliations ?

Dr. Amos is affiliated with 15 hospitals.

Hospital Affilations



  • Sacred Heart Hospital - Emerald Coast
    7800 US Highway 98 W, Miramar Beach, FL 32550
    • Currently 4 of 4 crosses
    Top 25%
  • West Florida Hospital
    Medical Oncology
    8383 N Davis Hwy, Pensacola, FL 32514
    • Currently 2 of 4 crosses
  • Mizell Memorial Hospital
    702 N Main St, Opp, AL 36467
    • Currently 1 of 4 crosses
  • Fort Walton Beach Medical Center
    Medical Oncology
    1000 Mar Walt Dr, Fort Walton Beach, FL 32547
    • Currently 1 of 4 crosses
  • South Baldwin Regional Medical Center
  • Santa Rosa Medical Center
  • North Okaloosa Medical Center
  • Sacred Heart Hospital - Pensacola
  • West Florida Reg Med Ctr, Pensacola, Fl
  • Healthsouth Emerald Coast Surgery Center
  • Baptist Health Care Systems
  • Baptist Hospital
  • West Florida Regional Hospital
  • Baptist Healthcare Systems
  • Twin Cities Hospital
  • Publications & Research

    Dr. Amos has contributed to 3 publications.
    Title Use of Sargramostim As Maintenance Therapy in Patients with Stage Iv Melanoma at High Risk for Systemic Recurrence.
    Date September 2007
    Journal Melanoma Research
    Title Postoperative Radiotherapy for Locally Advanced Colon Cancer.
    Date January 1997
    Journal Annals of Surgical Oncology

    BACKGROUND: The role of adjuvant postoperative radiotherapy for locally advanced colon cancer is not well documented. METHODS: Seventy-eight patients who underwent a complete resection of B2-C colon cancer received postoperative radiotherapy. Twenty-eight patients received < or = 45 Gy; 50 patients received 50-55 Gy. Twenty-seven patients received adjuvant fluorouracil-based chemotherapy. All patients were followed for a minimum of 3 years; no patients were lost to follow-up. RESULTS: The overall local control rate was 88%. The 5-year actuarial rate of local control was 96% after 50-55 Gy postoperative radiotherapy compared with 76% after < 50 Gy (p = 0.0095). Multivariate analysis of local control showed that only radiotherapy dose significantly influenced this end point. Cause-specific survival rates at 5 years were B2, 67%; B3, 90%; C1, 100%; C2, 61%; C3, 36%; and overall, 63%. Multivariate analysis of cause-specific survival showed that only stage significantly influenced this end point. Bowel obstruction caused by adhesions developed in three patients and required a laparotomy; radiation-induced sarcoma developed in one additional patient. CONCLUSIONS: Postoperative radiotherapy appears to reduce the risk of local recurrence in patients with locally advanced colon cancer. The optimal dose is probably 50-55 Gy at 1.8 Gy per fraction. Postoperative radiotherapy may improve cause-specific survival for patients with stages B3 and C2 cancers.

    Title Oropharyngeal Carcinoma Treated with Radiotherapy: a 30-year Experience.
    Date February 1996
    Journal International Journal of Radiation Oncology, Biology, Physics

    PURPOSE: This study was done to determine the outcome in patients with oropharyngeal carcinoma treated at the University of Florida with radiotherapy alone to the primary site, for comparison with reported results of other types of treatment. METHODS AND MATERIALS: Of a consecutive cohort of 785 patients with biopsy-proven, previously untreated, invasive squamous cell carcinoma of the oropharynx, this report is based on the 490 patients who had continuous-course irradiation with curative intent at the University of Florida between October 1964 and January 1991. All patients had a minimum 2-year follow-up. Forty-eight percent had Stage T3 or T4 disease, and 64% had clinically apparent neck node metastases. The median radiation dose was 68 Gy for once-a-day treatment and 76.8 Gy for twice-a-day treatment. Patients with advanced neck node disease had planned neck dissection(s) after radiotherapy. RESULTS: The overall local control rate after radiotherapy alone was 73%. The ultimate local control rate (including surgical salvage) was 78%. At 5 years, the probability of control of neck disease was 85%; control above the clavicles, 67%; absolute survival, 44%; cause-specific survival, 77%; distant metastasis (as the first or only site of failure), 11%. Thirteen patients (2.6%) experienced severe treatment complications. CONCLUSION: Radiotherapy results in tumor control and survival rates comparable with rates achieved with combined irradiation and surgery, with less morbidity.

    Similar doctors nearby

    Dr. Ancil Lindley

    Diagnostic Radiology
    41 years experience
    Crestview, FL

    Dr. Patricia Hambley

    Diagnostic Radiology
    30 years experience
    Crestview, FL

    Dr. Kerri Baden

    Diagnostic Radiology
    13 years experience
    Eglin Afb, FL

    Dr. Danae Mendez

    Diagnostic Radiology
    32 years experience
    Fort Walton Beach, FL

    Dr. Diana Edgar

    Diagnostic Radiology
    30 years experience
    Fort Walton Beach, FL

    Dr. Vincent Jones

    Diagnostic Radiology
    25 years experience
    Fort Walton Beach, FL
    Search All Similar Doctors